NEW YORK (GenomeWeb) – Life sciences tools startup Ultivue announced today that it has closed a $5.2 million Series A financing round that included Arch Venture Partners, Hansjoerg Wyss, and several private investors.

The company was founded to commercialize two fluorescence microscopy technologies, called DNA-PAINT and DNA-Exchange, developed at Harvard University's Wyss Institute for Biologically Inspired Engineering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.